Arix Bioscience Plc - Change of Broker
Change of Broker
(“Arix”, LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that it has appointed as joint corporate broker, with immediate effect, alongside its existing corporate broker ., :
For more information on Arix, please contact:
, Head of Investor Relations
+44 (0)20 7290 1072
+44 (0)203 714 1787
is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
is listed on the Main Market of the . For further information, please visit
Quick facts: Arix Bioscience PLC
Market Cap: £84.72 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE